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ABSTRACT 
 
Cold chain medicines are those that require special temperature-controlled cold storage to 
maintain their quality and efficacy. Cold chain management is important to ensure that the 
right quality is maintained throughout the supply chain. There lies a variety of reasons why 
cold chain management continues to be the challenge in India like lack of the consolidated list 
of cold chain medicines, lack of standard refrigeration guidelines for retail pharmacies, non-
uniformity in storage temperature instructions on the label, patient education and lack of 
awareness. The study aims to identify the challenges faced in the last mile delivery of such 
medicines in India and suggest practical recommendations for improvement that confirms the 
international best practices. More than 100 interviews were conducted with healthcare 
professionals like doctors, pharmacists, retail pharmacy experts, logistic partners, distributors 
and ex-regulators to understand the storage conditions and the possible solutions, especially at 
retail and customer level. An exhaustive list of cold chain medicines was framed with the 
databases of Indian hospitals, local drug distributors and drug retailers. Given the complexity 
of cold chain system in India, the guidelines for maintaining and managing the cold chain 
should be clearly available and then be mandatorily followed, in order to avoid the deleterious 
effects on such medicines due to storage and handling issues as elaborated in this study. 
Introduction 
 
 
What are Cold Chain Medicines?  
 
Cold chain medicines are those that requires special 
temperature-controlled cold storage to maintain their quality 
and efficacy. A cold chain is an uninterrupted series of storage 
and distribution activities that maintains products at a required 
temperature range of 2°C and 8°C or between -10°C and -
20°C as per their requirements [1].  
 
Why is Cold Chain Management important?  
 
Cold chain management is important to ensure that the right 
quality is maintained throughout the supply chain. There are 
standardized guidelines around the world focusing on the right 
storage and transportation, and adhering to these standards 
amidst varied climatic conditions is a huge challenge. Cold 
chain products are sensitive biological substances that can 
become less effective or lose their potency if not stored 
properly. So it is important that the right temperature is 
maintained throughout the distribution chain, starting from the 
dispatch of the product from the manufacturing site to when it 
reaches the patient [1].  
 
What is the Cold Chain Medicines market size in India? 
 
As per the AWACS data for the year 2016-17, the cold chain 
medicines contributed more the 6000 crores to the Indian 
pharma market which is roughly around 6% of the total Indian 
pharma market. While a great emphasis is put on the control 
and monitoring for storage and transport conditions from the 
manufacturers to the wholesalers, a lot of work has still to be 
done for the very „last mile‟ distribution steps [2].  
          CODEN (USA): IJPB07                                                                     ISSN: 2320-9267   
                                                                    
Indian Journal of Pharmaceutical and Biological Research (IJPBR) 
Journal homepage: www.ijpbr.in 
Bhatnagar et al / Indian J. Pharm. Biol. Res., 2018; 6 (1):34-41 
Research Article 35 
 
 
What is Cold Chain breach? 
 
Cold chain breaches are defined as temperature variations 
outside of the range of 2°C to 8°C lasting for more than 15 
minutes. The effectiveness and shelf life of a product greatly 
diminishes on being exposed to conditions beyond the 
required temperature range. There lies a variety of reasons 
why cold chain management continues to be challenge in India 
like lack of consolidated list of cold chain medicines, lack of 
standard refrigeration guidelines for retail pharmacies, non-
uniformity in storage temperature instructions on labeland 
patient education and lack of awareness [3].  
 
Objectives of the study 
 
The study aims to identify the challenges faced in the last mile 
delivery of such medicines in Indian system and suggest 
practical recommendations for improvement that conforms the 
international best practices.  
 
Methodology 
 
We conducted ~100 interviews with doctors, pharmacists, 
retail pharmacy experts, logistic partners, distributors and ex-
regulators to understand the gaps and the possible solutions for 
the cold chain maintenance especially at the retailer and 
consumer level. Besides this, an exhaustive research and 
literature review was carried out to identify the medicines that 
require cold chain storage. There is also enlistment of 
identified comprehensive list of cold chain medicines by 
referring to database of multiple hospitals, distributors and 
retailers available in India including AIOCD, AWACS 
database, 1mg drug database and then mapped it to a list of 
~174 salts with more than 2500 SKU‟s to arrive at a final list  
 
Challenges associated with the cold chain in India 
It is crucial to continuously monitor and maintain the cold 
chain in order to keep the pharmaceutical product‟s efficacy 
intact. For which, it is imperative to have an undisrupted, 
seamless and smooth functioning supply chain, however, it is 
not that easy in the Indian market and the concerned 
stakeholders face several challenges. 
 
Lack of a consolidated list of cold chain medicines 
 The Drugs and Cosmetics Act 1940 defines the life periods of 
drugs and conditions of storage under Schedule P but lacks a 
comprehensive list of medicines that require temperature 
regulation with clear storage instructions with upper and lower 
limit [4]. Many retailers and consumers believe that only 
insulins, vaccines and hormonal preparations require 
temperature control, but there are several other drug categories 
which do require temperature control. A consolidated list of 
such medicines reviewed by stakeholders including 
pharmacists, industry experts, registered medical practitioners, 
manufacturers and the regulators, can serve as a reference for 
retailers. The information or the list available internationally 
will not be of much help for Indian setting as there is lot of 
variations in climatic conditions and also the medicines used 
might be different in different countries. 
 
Lack of standard refrigeration guidelines for retail 
pharmacies 
 The medicines are stored in the same refrigerators as food and 
drinks with continuous opening and closing of refrigerators 
hampering the temperature maintenance. The refrigerators 
usually have insufficient space preventing the air to circulate 
freely and are also found to have insufficient ice packs with 
less space in freezers to cater the need of proper transport and 
delivery of cold chain medicines [5]. There is also lot of 
ambiguity where to store the medicine in the refrigerator 
(inside the freezer or outside). Most of the retail pharmacies 
are equipped with domestic refrigerators which are not 
prepared for contingencies like maintenance, defrosting, 
power failures, and temperature monitoring.   
 
Non-uniformity in storage temperature instructions on 
label 
The storage instructions on medicines are not well-written and 
ambiguous at times. Many pharmaceutical products do not 
carry any temperature instructions, while some products carry 
different instructions. 
Some of the challenges being faced are [6]:  
a) Some products do not carry any storage instruction.  
b) Some products carry storage instruction like “store at room 
temperature‟‟.  
c) The room temperature across the country varies and also 
varies according to the time of the year.  
d) Some products carry storage instruction as „‟store in cool 
place‟‟, but the temperature range is not specified.  
e) Some products carry instructions as „‟store in cool place 
below 25 C‟‟.   
 
So, such serious variations in labeling can be misleading and 
may make the last mile delivery of such specific medicines 
more challenging.  
 
Last mile challenge in the delivery of cold chain medicines 
for retailers and consumers 
 While a great emphasis is put on the control and monitoring 
for storage and transport conditions from the manufacturers to 
the wholesalers, a lot of work has still to be done for the very 
„last mile‟ distribution steps. The last mile is the end stage in 
the logistics chain where a shipment meets its ultimate 
destination. In pharma world it means from the manufacturer 
of the cold chain medicine to the patient. There is a lack of 
knowledge on the cost effective options for last mile delivery 
of cold chain medicines [7].  
 
Patient awareness and education 
 There is a major requirement to make patients and co-
habitués aware and also educate the patients on how their 
medicines have to be stored in compliance with the cold chain 
guidelines and the potential risks of temperature breach. 
Patients also lack the knowledge on how to transport and store 
their cold chain medicines while moving outdoors. 
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Recommendations  
 
Listing of cold chain medicines in the billing software 
 
 We have compiled a comprehensive list of cold chain 
medicines through extensive research and referring to 
database of multiple hospitals, distributors and retailers 
(Ref Appendix – III, IV).  
 Tagging cold chain medicines in the billing software 
used by retail pharmacies will provide more clarity and 
easy bifurcation between a cold medicine and a normal 
medicine. For this, the regulators should make it 
mandatory for all retailers to have a billing software with 
all cold chain medicines marked so as to identify which 
medicines demand a cold chain storage and transport. 
 The technology would also enable retail pharmacies to 
educate customers (e.g. by SMS alerts) regarding storage 
requirements of a particular cold chain medicine.  
 
Refrigeration guidelines for cold chain medicines 
 
Guidelines that conform with the WHO guidelines should be 
enforced [4]:  
 
Refrigerators at retails pharmacies  
 
 Refrigerators that open on the top are more efficient than 
vertical ones as hot air rises while cold air falls. 
 Maintain frozen icepacks in sufficient quantity to 
transport items that require cold storage in cold boxes. 
 Refrigerators and freezers should be placed at least at an 
arm length away from the wall, and also with sufficient 
in between space in case of multiple refrigerators and/or 
freezers placed in a room; this will increase the air 
circulation.  
 Under ideal conditions, rooms with multiple refrigerators 
and/or freezers should have air conditioning as 
refrigerators and freezers generate large amount of heat 
which can damage the equipment over time. If it is not 
possible to have air conditioning, fans should be installed 
around the equipment to increase airflow also ensuring 
the air flow in spaces behind the refrigerators. 
 Must be designed specifically for that purpose, must not 
be used to store food, blood, milk, drink or specimens 
(domestic refrigerators are not suitable for this purpose). 
 Must be of appropriate size for the quantity of stock to be 
stored (stock should not occupy more than 50% of space 
to allow adequate air circulation). Order frequency 
should be increased rather than compromising with the 
air flow by filling the refrigerator.  
 Must be defrosted every 6 to 8 weeks in case it is not 
self-defrosting. 
 Its integral thermometer should be calibrated at least 
annually to ensure true readings.  
 Must have an independently powered digital maximum 
and minimum thermometer which records the current 
temperature, regardless of the existence of integral 
refrigerator thermometer.  
 Must be regularly serviced according to manufacturer‟s 
instructions to ensure its proper functioning [5].  
 
Transporting Refrigerated Medicines 
 
 Suitable rigid containers should be used all the times to 
reduce damage to medicines during transit.  
 Temperature should be maintained based on the cool box 
and type of gel pack used; some commercial icepacks/gel 
packs contain a chemical product ensuring that icepack 
remains colder than normal water-filled icepacks.  
 Nowadays, ice boxes with sensors and temperature 
logger are also available that accurately records the 
temperature within the ice box, and should be considered 
whenever feasible [5].  
 
 
Storage while transit and after delivery 
 
 Upon arrival, medicine should be transferred to 
refrigerator immediately. 
 For overnight storage of medicines, a dedicated 
refrigerator or an electric portable storage unit that 
maintains the required temperature should be used.  
 The consumers must be instructed to store medicine in 
refrigerator immediately until usage and then should be 
placed back to refrigerator immediately after drawing up 
each recommended dose [5].  
  
Standard temperature instructions (Refer to Appendix I) 
 
The research indicated that there is an urgent need for 
stringent and uniform temperature instructions throughout the 
country. The regulatory authorities should provide 
unambiguous storage temperature instruction guidelines on the 
medicine label, also mentioning mandatory proper storage in 
the required temperature condition. Exact temperature range 
should always be specified on the labels like store in a cold 
place at +2°C to +8°C and do not keep in a freezer. Some of 
the points to ponder about the labelling information regarding 
temperature are:  
a) Exact temperature needs to be mentioned.  
b) Both upper and lower temperature range with exact 
temperature range needs to be mentioned.  
c) The temperature range needs to be consistent on all active 
molecules, same drug. Should not be different for different 
batch numbers.  
d) Exact temperature range (instead of “cool”, “cold”, “room 
temperature”) should be defined and labeled.  
 
Safeguarding during power outage 
 
In the event of power outage, a number of steps should be 
taken to minimize damage to the pharmaceutical products:  
a) The time of power outage should be noted.  
b) The refrigerator and freezer doors should not be opened 
during power outage.  
c) If the power outage continues for more than 24 hours than 
the products stored in freezer should be removed and packed 
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in dry ice. Ensure adequate amount of dry ice availability all 
the times. 
d) When the power is restored, the temperature in the 
refrigerator and freezer should be recorded, and monitored 
until the temperature returns to the desired temperature [5].  
These allows calculation of the time duration for which the 
product was stored beyond the desired temperature and hence, 
enabling risk assessment calculations of continued potency of 
the involved pharmaceutical product/s [8].  
 
Last mile challenge in the delivery of cold chain medicines 
 
There are various options available like vaccine carriers, cool 
boxes and gel packs depending on the time of cold chain 
required. Given the complex supply chain the manufacturer 
have little visibility on the last mile of the medicine as it 
reaches chemist shelves and finally to patients. The last mile is 
the most vulnerable point and still remains as the most 
unsolved issue of the supply chain. (Refer to Appendix II) 
 
Patient education 
 
The patient needs to be informed regarding the storage 
requirements of all cold chain medicines, an automated sms 
must be sent to the patient once a cold chain order is delivered 
or handed over to customer. The use of technology will enable 
this service once a medicine tagged as a cold chain medicine is 
sold from a retail pharmacy. Standard tips for the use of 
insulin can be written on all insulin products, some of 
instructions for the use of insulin products are as follows: 
 Insulin should be kept in the refrigerator between +2°C 
to +8°C. Do not keep in the freezer. 
 If you are using an insulin pen, you may store it outside 
refrigerator at room temperature not exceeding 30°C.  
 Never expose the product/s to direct heat or sunlight.  
 Check the label for the number of days it can be used 
after opening.  
 
Limitations of the study 
 
While the study aims at targeting day today operational issues 
faced at the retailer and consumer level while maintaining the 
cold chain process, the study has the following limitations.  
 The study only refers to the challenges faced by some of 
the supply chain stakeholders and it fails to address the 
issues faced at the manufacturing units for handling of 
such medicines.  
 The study does not evaluate the major public health 
issues pertaining to delivery of cold chain medicines in 
Indian Health care system.  
 
Conclusion 
 
Addressing the cold chain delivery system of medicine is the 
utmost need of hour especially under varied environmental 
and climatic conditions that our country possess. Given the 
complexity of cold chain system, the guidelines for 
maintaining and managing the cold chain should be clearly 
available and then be mandatorily followed, in order to avoid 
the deleterious effects on such medicines due to storage and 
handling issues as elaborated in this study. We would also 
recommend building further on this and making it a robust and 
technology based process in the Indian Health care setting.  
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Appendix – I 
Temperature Standards 
The Indian 
Pharmacopoeia [10] 
 Store in a dry, well-ventilated place at a temperature not exceeding 30º 
 Store in a refrigerator (2º to 8º). Do not freeze. 
 Store in a freezer: (-2º to -18º) 
 Store in a deep freezer: (Below -18º) 
Definitions in the WHO 
Guidance [9] 
 
 Store frozen: transported within a cold chain and stored at -20°C (4°F). Store at 2°-
8°C (36°-46°F): for heat sensitive products that must not be frozen. 
 Cool: Store between 8°-15°C (45°-59°F).  
 Room temperature: Store at 15°-25°C (59°-77°F).  
 Ambient temperature: Store at the surrounding temperature. This term is not widely 
used due to significant variation in ambient temperatures. It means "room 
temperature" or normal storage conditions, which means storage in a dry, clean, 
well-ventilated area at room temperatures between 15° to 25°C (59°-77°F) or up to 
30°C, depending on climatic conditions. 
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Appendix – II Last Mile Cold Chain Delivery  
 
 
 
 
 
The U.S. Pharmacopeia 
[9] 
 Cold: Any temperature not exceeding 8°C (46 °F). 
 Cool: Any temperature between 8° and 15° (46° and 59 °F) 
 Room temperature: The temperature prevailing in a work area. 
 Controlled room temperature: The temperature maintained thermostatically that 
encompasses at the usual and customary working environment of 20°-25° (68°-77 
°F). 
 Warm: Any temperature between 30° and 40°C (86° and 104 °F). 
 Excessive heat: Any temperature above 40° (104 °F). 
The European 
Pharmacopoeia [9] 
 Deep-freeze: below -15°C  
 Refrigerator: 2°C to 8°C 
 Cold or cool: 8°C to 15°C 
 Room temperature: 15°C to 25°C. 
The Japanese 
Pharmacopeia [9] 
 Cold: 1°C - 15°C 
 Standard temperature: 20°C 
 Ordinary temperature: 15°C - 25°C 
 Room temperature: 1°C - 30°C 
 Lukewarm: 30°C - 40°C 
Last mile cold chain delivery [6] 
Insulation options Cooling agents/device 
Cold boxes Vaccine carriers Water packs/ice packs Gel packs 
Depending on the model, 
cold boxes can be used to 
store these medicines for 
periods of up to two days 
or more [8].  
Current prequalified 
carriers have a cold life 
with frozen ice packs of 
between 18 and 50 hours at 
+43 °C [8].  
Water packs are flat, leak-proof 
plastic containers that can be filled 
with tap water. They are used to 
line the inside of the cold box or 
vaccine carrier. Water packs are 
used to keep medicines at the 
required temperature range inside 
cold boxes and vaccine carriers 
[8].  
Gel packs has the advantages of 
ease of use and storage, with the 
added benefit of being reusable if 
so desired. Additionally, the 
product that the gel pack is 
keeping cold will not get wet like 
it would with wet ice, as the 
refrigerant gel is sealed into a 
plastic pouch [8].  
Cold life without openings 
at +43 °C  for 2hrs-8hrs 
depending on ice packs 
used [8].  
Cold life without openings 
at +43 °C for 10 hrs – 20 
hrs depending on the ice 
packs used [8].  
The water packs will stay frozen 
from 24-36 hours in an insulated 
container, At room temperature 
can keep the cold chain for about 
3-4 hours depending on the 
insulation [8].  
The gel packs will stay frozen 
from 36-48 hours in an insulated 
container, At room temperature 
can keep the cold chain for about 
10-20 hrs depending on the 
insulation [8].  
Recommendations 
1 litre (minimum 2 
icepacks / gel packs of size 
- 185 x 90 x 22mm) 
0.80 Litres (equipped with 
slots for 4 standardized ice 
packs) 
Use standardized and proper 
insulated cool box, ice packs to be 
used in proper consistency (non 
reusable) 
Use standardized and proper 
insulated cool box, ice packs to be 
used in proper consistency 
(reusable) 
3 litre (minimum 4 
icepacks / gel packs of size 
- 185 x 90 x 22mm) 
2.46 Litres (equipped with 
slots for 4 standardized ice 
packs) 
Cost - Rs 100 - Rs1500 
(approx depending on the 
size) 
Cost - Rs 600 - Rs 8000 
(approx depending on the 
size) 
Cost - Rs 2 - Rs 20 (approx 
depending on the size) 
Cost - Rs 15 - Rs 100 (approx) 
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Appendix - III 
Recommended list of cold chain medicines form wise 
 
Salt Drug Form Salt Drug Form 
Abatacept Injection Daptomycin Injection 
Abciximab Injection Darbepoetin alfa Injection 
Adalimumab Injection Denosumab Injection 
Albumin Injection Diltiazem Injection 
Alprostadil Injection Dinoprostone Gel, Pessaries 
Amphotericin B Injection Docetaxel Injection 
Anti Rh D 
immunoglobulin 
Injection Doxorubicin (Liposomal) Injection 
Aprotinin + Fibrinogen 
+ Thrombin 
Injection Dulaglutide Injection 
Asparaginase Injection Epirubicin Injection 
Atracurium Injection Eptifibatide Injection 
Becaplermin Gel Erythropoietin Injection 
Bevacizumab Injection Etanercept Injection 
Bleomycin Injection Fibrinogen  Injection 
Botulinum Toxin Injection Filgrastim Injection 
Botulism Sera Injection Follicle Stimulating 
Hormone(FSH) 
Injection 
Calcitonin Injection, Nasal Spray Fosphenytoin Injection 
Calcium Folinate Injection Glatiramer Acetate Injection 
Carboprost Injection Glucagon Injection 
Caspofungin Injection Glutathione Injection 
Cetrorelix Injection Goserelin Injection 
Cetuximab Infusion Human Chronic 
Gonadotropin Hormone 
Injection 
Corticotropin Injection Human Gamma Globulin Infusion 
Cyclophosphamide Injection Human immunoglobulin Injection 
Dacarbazine Injection Human Normal 
Immunoglobulin 
Infusion 
Ifosfamide Injection Polyvalent 
Immunoglobulins 
Combination Modulation 
Infusion 
Infliximab Injection Poractant Alfa Injection 
Interferon Alpha 2A Injection Pemetrexed Injection 
Interferon Alpha 2B Injection Proparacaine Eye Drop 
Interferon Beta-1A Injection Recombinant Human 
Epidermal Growth Factor 
Gel 
Latanoprost Eye Drop Risperidone Injection 
Leuprolide/leuprorelin Injection Rituximab Injection 
Liraglutide Injection Rocuronium Injection 
Lixisenatide Injection Sirolimus Injection 
Lorazepam Injection Sodium Hyluronate  Injection 
Luteinizing Hormone Injection Somatostatin Injection 
Menotropins Injection Somatropin Injection 
N-butylcyanoacrylate Injection Streptokinase Injection 
Nicorandil Injection, Tablet Succinyl Choline Chloride Injection 
Nimotuzumab Injection Tenecteplase Injection 
Octreotide acetate Injection Teriparatide Injection 
Pancuronium Injection Terlipressin Injection 
Pegfilgrastim Injection Trastuzumab Injection 
Pegylated Interferon 
Alpha 2A 
Injection Triptorelin Injection 
Pegylated Interferon Injection Urofollitropin Injection 
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Alpha 2B 
Peliperidone Injection Vasopressin Injection 
Hyaluronic acid Injection   
Note: All the vaccines and insulin's are categorized under Cold Chain Medicines list 
Appendix - IV 
Recommended list of cold chain medicines as per group  
Antimicrobial Amphotericin B, Caspofungin injection, Daptomycin injection  
Anticancer Asparaginase, Bevacizumab, Bleomycin, Cetuximab, Cyclophosphamide injection, 
Dacarbazine, Docetaxel, Doxorubicin (Liposomal), Epirubicin, Ifosfamide, 
Leuprolide/leuprorelin, Nimotuzumab, Pemetrexed, Rituximab, Trastuzumab 
Anti-diabetics Insulins, Dulaglutide, Liraglutide, Lixisenatide 
Biologics Anti Rh D immunoglobulin, Human Gamma Globulin, Human immunoglobulin, 
Interferon Alpha 2A, Interferon Alpha 2B, Interferon Beta-1A,, Human Normal 
Immunoglobulin, Glatiramer Acetate, Adalimumab, Etanercept, Infliximab Abatacept, 
Pegylated Interferon Alpha 2A injection, Polyvalent Immunoglobulins Combination 
Modulation 
Hematological products Abciximab, Albumin, Aprotinin + Fibrinogen + Thrombin, Darbepoetin alfa, 
Eptifibatide, Erythropoietin, Filgrastim, N-butylcyanoacrylate, Pegfilgrastim, 
Streptokinase, Tenecteplase, Terlipressin  
Bone related Calcitonin, Denosumab, Hyaluronic acid inj, Sodium Hyluronate inj, Teriparatide  
CNS Fosphenytoin, Lorazepam injection, Risperidone inj, Paliperidone inj 
CVS Diltiazem, Nicorandil 
Respiratory Poractant Alfa 
Dermatological Becaplermin(Recombinant Platelet Derived Group Factor), Recombinant Human 
Epidermal Growth Factor 
Hormones Cetrorelix, Corticotropin, Follicle Stimulating Hormone(FSH), Luteinizing Hormone, 
Glucagon, Goserelin, Menotropins, Octreotide acetate, Somatostatin, Somatropin, 
Triptorelin, Urofollitropin, Vasopressin, Human Chronic Gonadotropin Hormone 
(HCG) 
Skeletal Muscle relaxant Atracurium, Pancuronium, Rocuronium, Succinyl Choline Chloride 
Prostaglandin Alprostadil, Carboprost, Dinoprostone, Latanoprost* 
Miscellaneous Botulinum Toxin (botox), Botulism Sera, Proparacaine, Sirolimus inj 
 
Note 1: All the vaccines and insulin’s are categorized under Cold Chain Medicines list.  
Note 2:*Other ophthalmic preparations like bmatoprost, travoprost can be stored between 2° to 25°C.  
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